TCF7转录激活MACC1调节有氧糖酵解促进直肠癌奥沙利铂耐药

严研; 周立庆; 夏建洪; 马婷婷

doi:10.19401/j.cnki.1007-3639.2024.08.001

您当前的位置：

首页 >

文章列表页 >

TCF7转录激活MACC1调节有氧糖酵解促进直肠癌奥沙利铂耐药

论著 | 更新时间：2025-12-31

- TCF7转录激活MACC1调节有氧糖酵解促进直肠癌奥沙利铂耐药
- TCF7 transcriptional activation of MACC1 regulates aerobic glycolysis and promotes oxaliplatin resistance in rectal cancer
- 中国癌症杂志 2024年34卷第8期页码：715-725
- 作者机构：
  
  淮安市第二人民医院，徐州医科大学附属淮安医院放疗科，江苏淮安 223000
- 作者简介：
  
  [ "严研（ORCID: 0000-0001-7948-931X），学士，主治医师。" ]
  周立庆（ORCID: 0000-0001-6788-0848），博士，主任医师。
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2024.08.001
  中图分类号： R735.3
- 收稿：2023-12-27，
  
  修回：2024-04-12，
  
  纸质出版：2024-08-30
- 稿件说明：
移动端阅览
严研, 周立庆, 夏建洪, 等. TCF7转录激活MACC1调节有氧糖酵解促进直肠癌奥沙利铂耐药[J]. 中国癌症杂志, 2024,34(8):715-725.

Yan YAN, Liqing ZHOU, Jianhong XIA, et al. TCF7 transcriptional activation of MACC1 regulates aerobic glycolysis and promotes oxaliplatin resistance in rectal cancer[J]. China Oncology, 2024, 34(8): 715-725.
严研, 周立庆, 夏建洪, 等. TCF7转录激活MACC1调节有氧糖酵解促进直肠癌奥沙利铂耐药[J]. 中国癌症杂志, 2024,34(8):715-725. DOI： 10.19401/j.cnki.1007-3639.2024.08.001.

Yan YAN, Liqing ZHOU, Jianhong XIA, et al. TCF7 transcriptional activation of MACC1 regulates aerobic glycolysis and promotes oxaliplatin resistance in rectal cancer[J]. China Oncology, 2024, 34(8): 715-725. DOI： 10.19401/j.cnki.1007-3639.2024.08.001.

摘要

背景与目的：

直肠癌是发生在直肠内壁的癌症，结肠癌转移相关基因-1（metastasis-associated in colon cancer 1，MACC1）能促进结肠癌细胞的耐药性。本研究旨在探究MACC1在直肠癌中对奥沙利铂耐药的影响及机制。

方法：

分析MACC1和转录因子7（transcription factor 7，TCF7）在直肠癌组织中的表达及MACC1富集的信号转导通路。采用实时荧光定量聚合酶链反应（real-time fluorescence quantitative polymerase chain reaction，RTFQ-PCR）检测直肠癌细胞及直肠癌奥沙利铂耐药细胞中MACC1和TCF7的表达，采用细胞计数试剂盒（cell counting kit-8，CCK-8）检测细胞活力，采用细胞集落形成实验检测细胞的增殖情况，采用Seahorse Biosciences XF96检测ECAR值、乳酸生成量和葡萄糖消耗量，采用蛋白质印迹法（Western blot）检测糖酵解相关蛋白的表达，采用双

荧光素酶报告基因和ChIP验证MACC1与TCF7之间的调控关系。采用GraphPad Prism 8.0对各组数据进行正态性检验与方差齐性分析，根据结果是否为正态分布进行单因素方差分析、

检验或Wilcoxon秩和检验。采用双侧检验，

0.05为差异有统计学意义。

结果：

MACC1和TCF7在直肠癌中表达上调，敲低MACC1显著抑制了直肠癌耐药细胞活力及不同浓度奥沙利铂处理后的IC

值，也降低了直肠癌奥沙利铂耐药细胞的增殖能力。过表达MACC1能够促进直肠癌细胞增殖和糖酵解能力。进一步研究发现，MACC1上游存在转录因子TCF7，本研究采用癌症基因组图谱计划（The Cancer Genome Atlas Program，TCGA）数据集分析了TCF7在直肠癌组织中的表达量，结果显示，敲低TCF7能够减弱MACC1对直肠癌细胞糖酵解能力及奥沙利铂耐药的促进作用。

结论：

TCF7/MACC1轴促进有氧糖酵解进而促进直肠癌细胞奥沙利铂耐药，提示靶向TCF7/MACC1轴或抑制有氧糖酵解途径可能是抑制直肠癌奥沙利铂耐药性的新的治疗方法。

Abstract

Background and purpose:

Rectal cancer occurs on the inner wall of the rectum

and metastasis-associated in colon cancer 1 (MACC1) can promote drug resistance in colon cancer cells. This study aimed to investigate the effect of MACC1 on oxaliplatin resistance in rectal cancer and its mechanism.

Methods:

Biosignal analysis of MACC1 and TCF7 expressions in rectal cancer tissues and signaling pathways enriched for MACC1 were carried out. The expressions of MACC1 and TCF7 in rectal cancer cells and rectal cancer oxaliplatin-resistant cells were detected by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR)

cell viability was detected by cell counting kit-8 (CCK-8)

and cell proliferation was detected by cell colony formation assay. ECAR values

lactate production and glucose consumption were detected by Seahorse Biosciences XF96. Western blot was used to detect the expressions of glycolysis-related proteins. Dual luciferase reporter gene and ChIP were used to validate the regulatory relationship between MACC1 and TCF7. Normality test and homogeneity of variance analysis was performed on the data of each group by GraphPad Prism 8.0. If it conformed to normal distribution

one-way ANOVA or

-test would be used for inter group comparison

otherwise the comparison between groups would be conducted using Wilcoxon rank sum test. Using

a two-sided test

0.05 was considered statistically significant.

Results:

MACC1 and TCF7 expressions were upregulated in rectal cancer

and knockdown of MACC1 significantly inhibited the viability of rectal cancer drug-resistant cells and the IC

values of different concentrations of oxaliplatin treatments

as well as reduced the proliferation ability of rectal cancer oxaliplatin-resistant cells. Overexpression of MACC1 was able to promote the proliferation and glycolytic capacity of rectal cancer cells. Further studies revealed that the transcription factor TCF7 existed in the upper reaches of MACC1. Besides

this study analyzed the data from Cancer Genome Atlas Program (TCGA)

and the result showed that knockdown of TCF7 was able to attenuate the promotional effect of overexpression of MACC1 on the glycolytic capacity and oxaliplatin resistance of rectal cancer cells.

Conclusion:

This study demonstrated that the TCF7/MACC1 axis could promote aerobic glycolysis and thus oxaliplatin resistance in rectal cancer cells. The findings suggest that targeting the TCF7/MACC1 axis or inhibiting the aerobic glycolysis pathway may be a novel therapeutic approach to inhibit oxaliplatin resistance in rectal cancer.

关键词

Keywords

references

ZHENG R S , ZHANG S W , ZENG H M , et al . Cancer incidence and mortality in China, 2016 [J ] . J Natl Cancer Cent , 2022 , 2 ( 1 ): 1 - 9 .

上海市抗癌协会大肠癌专业委员会 . 结直肠癌早筛、早诊、早治上海方案(2023年版) [J ] . 中国癌症杂志 , 2024 , 34 ( 1 ): 13 - 66 . DOI: 10.19401/j.cnki.1007-3639.2024.01.002 http://doi.org/10.19401/j.cnki.1007-3639.2024.01.002

Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association . Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition) [J ] . China Oncol , 2024 , 34 ( 1 ): 13 - 66 .

YANG Y , WANG H Y , CHEN Y K , et al . Current status of surgical treatment of rectal cancer in China [J ] . Chin Med J , 2020 , 133 ( 22 ): 2703 - 2711 .

WANG Y Q , SHEN L J , WAN J F , et al . Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: a new era for anal preservation [J ] . Front Immunol , 2022 , 13 : 1067036 .

CIARDIELLO F , CIARDIELLO D , MARTINI G , et al . Clinical management of metastatic colorectal cancer in the era of precision medicine [J ] . CA Cancer J Clin , 2022 , 72 ( 4 ): 372 - 401 .

TATARYN B , KRYZHANIVSKA A , HOLOTIUK V , et al . Chemotherapy in rectal cancer [J ] . Wiad Lek , 2021 , 74 ( 8 ): 1816 - 1823 .

KIM J K , MARCO M R , ROXBURGH C S D , et al . Survival after induction chemotherapy and chemoradiation versus chemoradiation and adjuvant chemotherapy for locally advanced rectal cancer [J ] . Oncologist , 2022 , 27 ( 5 ): 380 - 388 . DOI: 10.1093/oncolo/oyac025 http://doi.org/10.1093/oncolo/oyac025

ZHANG Z Y , YAO Q Z , LIU H Y , et al . Metabolic reprogramming-associated genes predict overall survival for rectal cancer [J ] . J Cell Mol Med , 2020 , 24 ( 10 ): 5842 - 5849 .

LIU C , JIN Y , FAN Z M . The mechanism of Warburg effect-induced chemoresistance in cancer [J ] . Front Oncol , 2021 , 11 : 698023 .

LIN J G , XIA L Z , OYANG L , et al . The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity [J ] . Oncogene , 2022 , 41 ( 7 ): 1024 - 1039 . DOI: 10.1038/s41388-021-02148-y http://doi.org/10.1038/s41388-021-02148-y

HOHMANN T , HOHMANN U , DEHGHANI F . MACC1-induced migration in tumors: current state and perspective [J ] . Front Oncol , 2023 , 13 : 1165676 .

ZHANG Q , ZHANG B , SUN L N , et al . Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation [J ] . Acta Biochim Biophys Sin , 2018 , 50 ( 8 ): 748 - 756 .

DUAN J M , CHEN L S , ZHOU M Y , et al . MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression [J ] . Oncol Rep , 2017 , 37 ( 5 ): 2583 - 2592 . DOI: 10.3892/or.2017.5519 http://doi.org/10.3892/or.2017.5519

ZHEN T T , DAI S J , LI H , et al . MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway [J ] . Oncotarget , 2014 , 5 ( 11 ): 3756 - 3769 . DOI: 10.18632/oncotarget.1993 http://doi.org/10.18632/oncotarget.1993

KORTÜM B , RADHAKRISHNAN H , ZINCKE F , et al . Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis [J ] . Oncogene , 2022 , 41 ( 39 ): 4446 - 4458 . DOI: 10.1038/s41388-022-02407-6 http://doi.org/10.1038/s41388-022-02407-6

CHENG C Y , XIE Z H , LI Y H , et al . PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis [J ] . Biomed Pharmacother , 2018 , 108 : 194 - 200 . DOI: S0753-3322(18)33137-8 http://doi.org/S0753-3322(18)33137-8

LIU J , PAN C Q , GUO L H , et al . A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway [J ] . J Hematol Oncol , 2016 , 9 ( 1 ): 76.

LI M X , CHE N , JIN Y , et al . CDKN3 overcomes bladder cancer cisplatin resistance via LDHA-dependent glycolysis reprogramming [J ] . Onco Targets Ther , 2022 , 15 : 299 - 311 .

WAINBERG Z A , BEKAII-SAAB T , BOLAND P M , et al . First-line liposomal irinotecan with oxaliplatin, 5-fluorouraciland leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: a phase Ⅰ/Ⅱ study [J ] . Eur J Cancer , 2021 , 151 : 14 - 24 .

PARK S H , LIM D H , SOHN T S , et al . A randomized phase Ⅲ trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial [J ] . Ann Oncol , 2021 , 32 ( 3 ): 368 - 374 .

KOBA R , FUJITA H , NISHIBORI M , et al . Quantitative evaluation of the in tratumoral distribution of platinum in oxaliplatin-treated rectal cancer: in situ visualization of platinum via synchrotron radiation X-ray fluorescence spectrometry [J ] . Int J Cancer , 2020 , 146 ( 9 ): 2498 - 2509 .

LI H F , WANG C M , LAN L X , et al . PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway [J ] . Front Cell Dev Biol , 2021 , 9 : 719192 .

PAN Z H , ZHENG J , ZHANG J B , et al . A novel protein encoded by exosomal CircATG4B induces oxaliplatin resistance in colorectal cancer by promoting autophagy [J ] . Adv Sci , 2022 , 9 ( 35 ): e2204513.

LI H , CHEN J H , LIU J , et al . CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism [J ] . Exp Cell Res , 2021 , 409 ( 1 ): 112892.

LI N , LI Y , GAO H B , et al . Forkhead-box A3 (FOXA3) represses cancer stemness and partially potentiates chemosensitivity by targeting metastasis-associated in colon cancer 1 (MACC1) signaling pathway in colorectal cancer cells [J ] . Curr Cancer Drug Targets , 2020 .

QIU X F , XU Q H , LIAO B L , et al . Circ-CCS regulates oxaliplatin resistance via targeting miR-874-3p/HK2 axis in colorectal cancer [J ] . Histol Histopathol , 2023 , 38 ( 10 ): 1145 - 1156 .

LV M M , JIAO Y J , YANG B W , et al . MACC1 as a potential target for the treatment and prevention of breast cancer [J ] . Biology , 2023 , 12 ( 3 ): 455.

LIN L , LIU Y T , PAN C Q , et al . Gastric cancer cells escape metabolic stress via the DLC3/MACC1 axis [J ] . Theranostics , 2019 , 9 ( 7 ): 2100 - 2114 . DOI: 10.7150/thno.29538 http://doi.org/10.7150/thno.29538

WANG X Y , ZHANG H Y , YANG H O , et al . Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer [J ] . Mol Oncol , 2020 , 14 ( 3 ): 539 - 555 . DOI: 10.1002/1878-0261.12629 http://doi.org/10.1002/1878-0261.12629

LIU H , LI D X , SUN L N , et al . Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression [J ] . Mol Cancer , 2022 , 21 ( 1 ): 74.

GUO Y X , GUO Y Y , CHEN C , et al . Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis [J ] . Mol Cancer , 2021 , 20 ( 1 ): 93.

PENG Y , XIAO L P , RONG H X , et al . Single-cell profiling of tumor-infiltrating TCF1/TCF7 + T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer [J ] . Oral Oncol , 2021 , 119 : 105348 .

LIU H Q , ZHANG H , LIU X Q , et al . Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth [J ] . Cancer Lett , 2023 , 555 : 216040 .

浏览量

1845

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

机体组分在直肠癌患者术后长期预后预测中的价值及模型建立

直肠癌外科治疗的创新模式探讨

直肠癌患者经肛门或腹腔镜行全直肠系膜切除术后的生活质量分析：一项回顾性队列研究

直肠癌DCE-MRI定量分析参数与微血管生成的相关性分析

探讨氨磷汀对局部晚期直肠癌新辅助放疗同期伊立替康化疗的减毒作用：对154例病例的回顾性队列研究